Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
about
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
@ast
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
@en
type
label
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
@ast
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
@en
prefLabel
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
@ast
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
@en
P2093
P2860
P1476
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
@en
P2093
Agnès Fromont
Audrey Rico
Ayman Tourbah
Bertrand Bourre
Bruno Stankoff
Caroline Papeix
Catherine Lubetzki
Christine Lebrun
Céline Louapre
David Brassat
P2860
P356
10.1212/NXI.0000000000000346
P577
2017-04-14T00:00:00Z